Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 23097583.
- Also identified by DOI 10.1093/cid/cis917.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The long-term treatment of human immunodeficiency virus (HIV)-infected children with combination antiretroviral therapy (cART) requires assessment of potential adverse effects, such as osteoporosis. Longitudinal data on bone mineral density (BMD) in HIV-infected children showed that cumulative treatment with cART had a positive impact on BMD over time.
Medical subject headings
- Antiretroviral Therapy, Highly Active
- Bone Density
- HIV Infections
- Osteoporosis